MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: Biocompatibles UK Ltd / BTG Plc
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

SIO and BTG Announce Recipients of Immuno-Oncology/Interventional Oncology Grant Program - The Society of Interventional Oncology (SIO) and BTG plc announce their 2018 Interventional Oncology/Immuno-Oncology research grant recipients - SIO-Central.org / BTGplc.com
SIO and BTG Announce Recipients of Immuno-Oncology/Interventional Oncology Grant Program

 

NewswireToday - /newswire/ - Washington, DC, United States, 2018/04/04 - The Society of Interventional Oncology (SIO) and BTG plc announce their 2018 Interventional Oncology/Immuno-Oncology research grant recipients - SIO-Central.org / BTGplc.com. LSE: BTG

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The Society of Interventional Oncology (SIO), an international organisation working to nurture and support interventional oncology worldwide, and BTG plc, a global healthcare company focused on Interventional Medicine, announce their 2018 Interventional Oncology/Immuno-Oncology research grant recipients.

The investigators and project proposals that have been awarded grants are:

• Rony Avritscher
University of Texas MD Anderson Cancer Center
Strategies to Modulate Liver Tumor Immune Microenvironment after Catheter-based Drug Delivery

• Terence Gade, University of Pennsylvania
University of Pennsylvania
Characterization of the Immunobiologic Response Following Transarterial Chemoembolization of HCC

• Samdeep Mouli
Northwestern University
Y90 Radioembolization Combined with Immune Checkpoint Blockade in an Animal Model of Hepatocellular

• Isabel Newton
University of California, San Diego
Effects of Cryoablation on Hepatocellular Carcinoma Cancer Stem Cells and the Immune Response

• Paul Thevenot
Ochsner Health System
Tumor-Induced Tolerance in Driving Embolization Resistance and Waitlist/Transplant Outcomes

“We are very pleased that with the continued generosity of BTG, SIO has been able to fund a second round of highly meritorious, cutting-edge research that combines the strengths of interventional oncology and immuno-oncology two disciplines that hold great promise for improving cancer therapy,” stated S. Nahum Goldberg, MD, SIO Interventional/Immuno-oncology Working Group Chair, and Vice-Chair for Research and Head of the Interventional Oncology Unit, Hadassah Hebrew University Medical Center in Jerusalem, Israel. He continued,“Once again, the large number of high-quality submissions to this grant call attests to the sustained intense interest of interventional oncologists worldwide to continue to advance our field through robust scientific inquiry and clinical study. We’re proud that to date, SIO has been able to fund nine projects representing a diverse set of outstanding investigators and projects.”

“As a leader in Interventional Oncology therapies, BTG is proud to support this independent research fund in partnership with the SIO,” said Karen Skinner, BTG’s Vice President of Immuno-Oncology R&D. “We’re thrilled by the quality of these proposals and to see Interventional Radiologists working alongside their colleagues in the Oncology community to unlock the potential of combining these therapies. We believe this collaborative approach is the best way to accelerate our understanding of this field, and help expand the number of cancer patients who might benefit from the immuno-oncology revolution.”

The Interventional Oncology/Immuno-Oncology research grant program was established in 2017 to fund initiatives that evaluate how interventional oncology therapies stimulate the immune system; combine loco-regional and immunotherapy approaches to improve clinical outcome; and improve the understanding of the underlying mechanisms that cause different therapies to influence adaptive and innate immunity, as well as underlying inflammation and tumorigenesis.

Grant recipients were chosen by the SIO Interventional Oncology/Immuno-Oncology Working Group, which includes both interventional radiologists and immuno-oncologists.

About Society of Interventional Oncology (SIO)
SIO (sio-central.org) serves as the only membership-based organization dedicated wholly to the emerging field of Interventional Oncology (IO), working to establish, nurture, and support IO as the fourth pillar of cancer therapy alongside medical, surgical, and radiation oncology worldwide. IO therapies, such as embolization and tumor ablation, combine the expertise of oncology and radiology and use imaging technology to diagnose and treat localized cancers in ways that are precisely targeted and minimally or non-invasive. The society hosts the annual World Conference on Interventional Oncology (WCIO). For more information, please visit: sio-central.org

About BTG
BTG (BTGplc.com | btg-im.com) is a global healthcare company focused on Interventional Medicine. Our innovative medical technology helps physicians treat their patients through minimally invasive procedures. We have a growing portfolio of products that advance the treatment of cancer, vascular conditions and severe emphysema.

SIO Contact: Amanda Winger O’Kane, Marketing & Communications
P: +1 202-367-1164 - E: aokane[.]sio-central.org.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Biocompatibles UK Ltd / BTG Plc

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


SIO and BTG Announce Recipients of Immuno-Oncology/Interventional Oncology Grant Program

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Chris Sampson - BTGplc.com 
+44(0)20 7575 1595 / +44(0)77 7325 1178 (mobile) chris.sampson[.]btgplc.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Biocompatibles UK Ltd / BTG Plc securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Biocompatibles UK Ltd / BTG Plc / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

Global Bio-based Chemicals Market is Expected to Grow At A CAGR of 16.67% by 2027 According to Inkwood Research
Global Diabetes Drugs Market Forecast 2019-2027 Reports Inkwood Research
Dysport® Now Approved in the UK for Symptomatic Treatment of Upper Limb Spasticity in Children with Cerebral Palsy
Human Microbiome Market to Reach .08 Billion by 2023, Powered by the High Growth in Over-the-Counter Probiotics Finds Frost & Sullivan
BASF Launches Hepacor in Switzerland for the Dietary Management of Non-Alcoholic Fatty Liver Disease
FDA Grants Priority Review to Genentech’s Risdiplam for Spinal Muscular Atrophy
Ipsen Presents New Analyses Utilizing Modern Data Mining Approaches At ISPOR Europe 2019
Global Opioids Drugs Market is Projected to Grow At a CAGR of 2.52% by 2027 Reports Inkwood Research
Global Bio-Based Chemicals Market Projected to Grow At a CAGR of 16.67% by 2027 Finds Inkwood Research
The Global Animal Nutrition Market Projected to Grow At a CAGR of 5.94% by 2027 Finds Inkwood Research
FDA Approves Genentech’s Rozlytrek (entrectinib) for People With ROS1-Positive, Metastatic Non-small Cell Lung Cancer
BTG to Invest in Chinese Medical Isotope Diagnosis and Treatment Company Chengdu New Radiomedicine Technology
Genentech Announces Positive Results for First Global Phase III Study Investigating One-dose XOFLUZA (Baloxavir Marboxil) in Children With the Flu
Debiopharm and Ipsen Extend Their Strategic Decapeptyl® (triptorelin) Partnership for Another 15 Years
GE Healthcare and World Courier Collaborate to Drive Commercialization of Cell and Gene Therapies

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  RightITnow, Inc.

Visit  Limelon Advertising, Co.





 
  ©2020 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)